Advertisement
Screener

PRECIGEN, INC. (PGEN) Other Comprehensive Income (Loss), Net of Tax

PRECIGEN, INC. Other Comprehensive Income (Loss), Net of Tax

PRECIGEN, INC. (PGEN) reported Other Comprehensive Income (Loss), Net of Tax of -$12.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04

  • PRECIGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$12.00K.
  • PRECIGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$24.00K.
  • PRECIGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$17.00K.
  • PRECIGEN, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $13.00K, a 85.71% increase year-over-year.
  • PRECIGEN, INC. other comprehensive income (loss), net of tax for fiscal 2025 was -$5.00K.
  • PRECIGEN, INC. other comprehensive income (loss), net of tax for fiscal 2024 was -$956.00K, a 162.04% decline from fiscal 2023.
  • PRECIGEN, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $1.54M.
  • PRECIGEN, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$3.69M.
Period endOther Comprehensive Income (Loss), Net of Tax 3 monthOther Comprehensive Income (Loss), Net of Tax 3 month as first filedOther Comprehensive Income (Loss), Net of Tax 6 monthOther Comprehensive Income (Loss), Net of Tax 9 monthOther Comprehensive Income (Loss), Net of Tax 12 month
2026-06-30-$12.00K
10-Q · filed 2026-08-04
-$36.00K
10-Q · filed 2026-08-04
-$53.00K
derived: sum of 3 quarters · filed 2026-08-04
-$40.00K
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$24.00K
10-Q · filed 2026-05-13
-$41.00K
derived: sum of 2 quarters · filed 2026-05-13
-$28.00K
derived: sum of 3 quarters · filed 2026-05-13
-$29.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$17.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$4.00K
derived: sum of 2 quarters · filed 2026-03-25
-$5.00K
derived: sum of 3 quarters · filed 2026-08-04
-$5.00K
10-K · filed 2026-03-25
2025-09-30$13.00K
10-Q · filed 2025-11-13
$12.00K
derived: sum of 2 quarters · filed 2026-08-04
$12.00K
10-Q · filed 2025-11-13
2025-06-30-$1.00K
10-Q · filed 2026-08-04
-$1.00K
10-Q · filed 2026-08-04
2024-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$6.00K
derived: sum of 2 quarters · filed 2026-03-25
-$106.00K
derived: sum of 3 quarters · filed 2026-03-25
-$956.00K
10-K · filed 2026-03-25
2024-09-30$7.00K
10-Q · filed 2025-11-13
-$105.00K
derived: sum of 2 quarters · filed 2025-11-13
-$955.00K
10-Q · filed 2025-11-13
$659.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-06-30-$112.00K
10-Q · filed 2025-08-12
-$962.00K
10-Q · filed 2025-08-12
$652.00K
derived: sum of 3 quarters · filed 2026-03-25
-$391.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-03-31-$850.00K
10-Q · filed 2025-05-14
$764.00K
derived: sum of 2 quarters · filed 2026-03-25
-$279.00K
derived: sum of 3 quarters · filed 2026-03-25
-$98.00K
derived: sum of 4 quarters · filed 2026-03-25
2023-12-31$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$571.00K
derived: sum of 2 quarters · filed 2026-03-25
$752.00K
derived: sum of 3 quarters · filed 2026-03-25
$1.54M
10-K · filed 2026-03-25
2023-09-30-$1.04M
10-Q · filed 2024-11-14
-$862.00K
derived: sum of 2 quarters · filed 2024-11-14
-$73.00K
10-Q · filed 2024-11-14
$3.62M
derived: sum of 4 quarters · filed 2025-03-19
2023-06-30$181.00K
10-Q · filed 2024-08-14
$970.00K
10-Q · filed 2024-08-14
$4.66M
derived: sum of 3 quarters · filed 2025-03-19
$2.04M
derived: sum of 4 quarters · filed 2025-03-19
2023-03-31$789.00K
10-Q · filed 2024-05-14
$4.48M
derived: sum of 2 quarters · filed 2025-03-19
$1.86M
derived: sum of 3 quarters · filed 2025-03-19
-$1.00M
derived: sum of 4 quarters · filed 2025-03-19
2022-12-31$3.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$1.07M
derived: sum of 2 quarters · filed 2025-03-19
-$1.79M
derived: sum of 3 quarters · filed 2025-03-19
-$3.69M
10-K · filed 2025-03-19
2022-09-30-$2.63M
10-Q · filed 2023-11-09
-$5.48M
derived: sum of 2 quarters · filed 2023-11-09
-$7.38M
10-Q · filed 2023-11-09
-$8.70M
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30-$2.86M
10-Q · filed 2023-08-09
-$4.76M
10-Q · filed 2023-08-09
-$6.07M
derived: sum of 3 quarters · filed 2024-03-19
-$7.10M
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31-$1.90M
10-Q · filed 2023-05-10
-$3.21M
derived: sum of 2 quarters · filed 2024-03-19
-$4.24M
derived: sum of 3 quarters · filed 2024-03-19
-$3.44M
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31-$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-$2.34M
derived: sum of 2 quarters · filed 2024-03-19
-$1.54M
derived: sum of 3 quarters · filed 2024-03-19
-$3.79M
10-K · filed 2024-03-19
2021-09-30-$1.03M
10-Q · filed 2022-11-09
-$231.00K
derived: sum of 2 quarters · filed 2022-11-09
-$2.48M
10-Q · filed 2022-11-09
$153.00K
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30$795.00K
10-Q · filed 2022-08-08
-$1.46M
10-Q · filed 2022-08-08
$1.18M
derived: sum of 3 quarters · filed 2023-03-06
$3.19M
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31-$2.25M
10-Q · filed 2022-05-09
$384.00K
derived: sum of 2 quarters · filed 2023-03-06
$2.40M
derived: sum of 3 quarters · filed 2023-03-06
$3.10M
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31$2.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$4.65M
derived: sum of 2 quarters · filed 2023-03-06
$5.35M
derived: sum of 3 quarters · filed 2023-03-06
$4.51M
10-K · filed 2023-03-06
2020-09-30$2.01M
10-Q · filed 2021-11-08
$2.72M
derived: sum of 2 quarters · filed 2021-11-08
$1.87M
10-Q · filed 2021-11-08
$7.51M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$704.00K
10-Q · filed 2021-08-09
-$139.00K
10-Q · filed 2021-08-09
$5.50M
derived: sum of 3 quarters · filed 2022-03-01
$599.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$843.00K
10-Q · filed 2021-05-10
$4.79M
derived: sum of 2 quarters · filed 2022-03-01
-$105.00K
derived: sum of 3 quarters · filed 2022-03-01
-$20.00K
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$5.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$738.00K
derived: sum of 2 quarters · filed 2022-03-01
$823.00K
derived: sum of 3 quarters · filed 2022-03-01
$1.16M
10-K · filed 2022-03-01
2019-09-30-$4.90M
10-Q · filed 2019-11-12
-$4.81M
derived: sum of 2 quarters · filed 2020-08-10
-$4.48M
10-Q · filed 2020-11-09
-$10.31M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$85.00K
10-Q · filed 2020-08-10
$417.00K
10-Q · filed 2020-08-10
-$5.41M
derived: sum of 3 quarters · filed 2021-03-01
-$6.42M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$332.00K
10-Q · filed 2020-05-11
-$5.50M
derived: sum of 2 quarters · filed 2021-03-01
-$6.51M
derived: sum of 3 quarters · filed 2021-03-01
-$18.66M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$5.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$6.84M
derived: sum of 2 quarters · filed 2021-03-01
-$18.99M
derived: sum of 3 quarters · filed 2021-03-01
-$13.13M
10-K · filed 2021-03-01
2018-09-30-$1.01M
10-Q · filed 2019-11-12
-$13.16M
derived: sum of 2 quarters · filed 2019-11-12
-$7.30M
10-Q · filed 2019-11-12
-$6.09M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$12.15M
10-Q · filed 2019-08-09
-$6.29M
10-Q · filed 2019-08-09
-$5.08M
derived: sum of 3 quarters · filed 2020-03-02
$2.40M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$5.86M
10-Q · filed 2019-05-09
$5.91M
10-Q · filed 2018-05-10
$7.07M
derived: sum of 2 quarters · filed 2020-03-02
$14.56M
derived: sum of 3 quarters · filed 2020-03-02
$23.32M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$8.70M
derived: sum of 2 quarters · filed 2020-03-02
$17.45M
derived: sum of 3 quarters · filed 2020-03-02
$20.69M
10-K · filed 2020-03-02
2017-09-30$7.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$16.25M
derived: sum of 2 quarters · filed 2017-11-09
$19.48M
10-Q · filed 2017-11-09
$8.59M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$8.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$11.99M
10-Q · filed 2017-08-09
$1.10M
derived: sum of 3 quarters · filed 2019-03-01
-$2.55M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$3.23M
10-Q · filed 2017-05-10
-$7.66M
derived: sum of 2 quarters · filed 2019-03-01
-$11.31M
derived: sum of 3 quarters · filed 2019-03-01
-$21.52M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$10.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$14.54M
derived: sum of 2 quarters · filed 2019-03-01
-$24.76M
derived: sum of 3 quarters · filed 2019-03-01
-$23.47M
10-K · filed 2019-03-01
2016-09-30-$3.65M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$13.86M
derived: sum of 2 quarters · filed 2016-11-09
-$12.58M
10-Q · filed 2016-11-09
-$20.12M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$10.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$8.93M
10-Q · filed 2016-08-09
-$16.48M
derived: sum of 3 quarters · filed 2018-03-01
-$19.35M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$1.28M
10-Q · filed 2016-05-10
-$6.26M
derived: sum of 2 quarters · filed 2018-03-01
-$9.13M
derived: sum of 3 quarters · filed 2018-03-01
-$8.29M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$7.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
-$10.42M
derived: sum of 2 quarters · filed 2018-03-01
-$9.58M
derived: sum of 3 quarters · filed 2018-03-01
-$12.67M
10-K · filed 2018-03-01
2015-09-30-$2.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$2.03M
derived: sum of 2 quarters · filed 2015-11-09
-$5.13M
10-Q · filed 2015-11-09
-$5.20M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$840.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
-$2.25M
10-Q · filed 2015-08-10
-$2.33M
derived: sum of 3 quarters · filed 2017-03-01
-$2.29M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$3.09M
10-Q · filed 2015-05-11
-$3.17M
derived: sum of 2 quarters · filed 2017-03-01
-$3.13M
derived: sum of 3 quarters · filed 2017-03-01
-$3.21M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$79.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$36.00K
derived: sum of 2 quarters · filed 2017-03-01
-$122.00K
derived: sum of 3 quarters · filed 2017-03-01
-$12.00K
10-K · filed 2017-03-01
2014-09-30$43.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
-$43.00K
derived: sum of 2 quarters · filed 2014-11-13
$67.00K
10-Q · filed 2014-11-13
$114.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$86.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$24.00K
10-Q · filed 2014-08-14
$71.00K
derived: sum of 3 quarters · filed 2016-02-29
$64.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$110.00K
10-Q · filed 2014-05-09
$157.00K
derived: sum of 2 quarters · filed 2016-02-29
$150.00K
derived: sum of 3 quarters · filed 2016-02-29
2013-12-31$47.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$40.00K
derived: sum of 2 quarters · filed 2016-02-29
$79.00K
10-K · filed 2016-02-29
2013-09-30-$7.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07
$32.00K
10-Q · filed 2013-11-07
2013-06-30$39.00K
10-Q/A · filed 2013-10-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Immunome Inc. (IMNM)United States$2.538B-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67